Life sciences venture capital firm Atlas Venture now has $350 million in fresh capital to invest in the early stage biotech companies in the U.S. and around the world. The new fund is Cambridge, MA-based Atlas’ eleventh. Atlas partner Bruce Booth says in a blog post that the firm began raising funds in April, bringing […]
NYS Entity Status
NYS Filing Date
OCTOBER 04, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - ATLAS SELECT FUND, LLC
AROUND THE WEB
- Atlas Venture Unveils New $350M Fund for Seed Biotech Investments
By Frank Vinluan - Thursday Jun 29, 2017
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]
- A Winning Design for a New York Monument to Gay and Transgender People
By JOSHUA BARONE - Sunday Jun 25, 2017
Gov. Andrew M. Cuomo announced that the artist Anthony Goicolea had been selected to design the monument in Hudson River Park in Manhattan.
- Millions Meant for Rail Tunnel Subsidize Ferry Rides for a Few
By PATRICK McGEEHAN - Thursday Jul 6, 2017
After canceling a Hudson River train tunnel, Gov. Chris Christie diverted some of the funding to a lightly used Seastreak service to Jersey City and Hoboken.
- Dan Loeb buys a chunk of Nestle, blasts ‘staid’ culture
By Carleton English - Monday Jun 26, 2017
Dan Loeb just placed his biggest bet ever on a chocolate company. The activist investor’s hedge fund Third Point LLC amassed a $3.5 billion stake in Nestle, the world’s largest packaged foods company, representing roughly 1.25 percent of the Swiss-based company’s shares. Loeb is hoping to reinvigorate the brand amid changing food tastes as well...